Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 27 min 47 sec ago

GE Healthcare Announces European Union Approval of VIZAMYL(TM) (Flutemetamol (18F) Solution for Injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer’s Disease

Mon, 09/01/2014 - 18:43
PET Imaging Agent Receives Marketing Authorisation from the European Commission CHALFONT ST. GILES, England--(Healthcare Sales & Marketing Network)--GE Healthcare announced today that VIZAMYL™ (flutemetamol (18F) solution for injection) has received mar...
Biopharmaceuticals, Devices, Radiology, Oncology, Regulatory
GE Healthcare, VIZAMYL, Flutemetamol, Positron Emission Tomography

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong